
T2 Biosystems TTOO
Quarterly report 2024-Q3
added 11-14-2024
T2 Biosystems Cash Conversion Cycle 2011-2026 | TTOO
Annual Cash Conversion Cycle T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.3 | 95.3 | 66.6 | 130 | 120 | 108 | 57.7 | 20.8 | -66.4 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 130 | -66.4 | 69.2 |
Quarterly Cash Conversion Cycle T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.8 | 67.8 | 66.4 | - | 74.4 | 60.4 | 76 | - | 53.3 | 54.7 | 59.9 | - | 50.4 | 54.6 | 59.9 | - | 88.7 | 182 | 142 | 84 | 154 | 143 | 118 | 90.9 | 66.1 | 41.5 | 44.5 | 25.7 | 38.5 | 44.6 | 38.5 | 32.8 | 27.5 | 30.1 | 29 | 33.3 | 32.1 | 59.7 | 138 | 154 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 182 | 25.7 | 72 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
111 | $ 114.87 | -0.65 % | $ 34.9 B | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.61 | -2.35 % | $ 2.14 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 24.61 | -1.48 % | $ 684 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.85 | - | $ 1.16 B | ||
|
Illumina
ILMN
|
142 | $ 126.55 | -1.54 % | $ 20.1 B | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 15.29 | -1.99 % | $ 462 M | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 83.38 | -0.87 % | $ 5.63 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 166.76 | -2.61 % | $ 8.27 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
79.6 | $ 82.62 | -6.64 % | $ 10.4 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 16.99 | -0.73 % | $ 380 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 1.93 | - | $ 8.54 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.13 | -1.49 % | $ 20 B | ||
|
Precipio
PRPO
|
19.9 | $ 30.2 | -1.64 % | $ 48.5 M | ||
|
Personalis
PSNL
|
-11.5 | $ 5.54 | -7.05 % | $ 328 M | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 7.28 | 0.14 % | $ 304 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 416.18 | -1.23 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
172 | $ 2.13 | -2.06 % | $ 4.89 M | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 101.17 | -1.98 % | $ 8.34 B | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 261.16 | -0.86 % | $ 21.7 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 469.03 | 0.21 % | $ 177 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.62 | -3.8 % | $ 61.9 M | ||
|
Neogen Corporation
NEOG
|
150 | $ 9.29 | -1.75 % | $ 2.01 B | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 59.4 | -2.62 % | $ 3.55 B | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.67 | 0.7 % | $ 1.11 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.83 | -0.1 % | $ 447 M | ||
|
Natera
NTRA
|
81.5 | $ 199.57 | -2.36 % | $ 19.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 196.11 | -0.26 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M |